Prognostic role of the controlling nutritional status (CONUT) score in patients with biliary tract cancer: a meta-analysis

References

• Valle JW, Kelley RK, Nervi B, et al. Biliary tract cancer. Lancet. 2021;397(10272):1–13. doi: 10.1016/s0140-6736(21)00153-7.
   PubMed Web of Science ®Google Scholar
• Charbel H, Al-Kawas FH. Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep. 2011;13(2):182–187. doi: 10.1007/s11894-011-0178-8.
   PubMedGoogle Scholar
• Tariq NU, McNamara MG, Valle JW. Biliary tract cancers: current knowledge, clinical candidates and future challenges. Cancer Manag Res. 2019;11:2623–2642. doi: 10.2147/cmar.S157092.
   PubMed Web of Science ®Google Scholar
• Shroff RT, Kennedy EB, Bachini M, et al. Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol. 2019;37(12):1015–1027. doi: 10.1200/jco.18.02178.
   PubMed Web of Science ®Google Scholar
• Bridgewater J, Lopes A, Wasan H, et al. Prognostic factors for progression-free and overall survival in advanced biliary tract cancer. Ann Oncol. 2016;27(1):134–140. doi: 10.1093/annonc/mdv483.
   PubMed Web of Science ®Google Scholar
• Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40(3):472–477. doi: 10.1016/j.jhep.2003.11.030.
   PubMed Web of Science ®Google Scholar
• Mantzorou M, Koutelidakis A, Theocharis S, et al. Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis? Nutr Cancer. 2017;69(8):1151–1176. doi: 10.1080/01635581.2017.1367947.
   PubMed Web of Science ®Google Scholar
• Kazi M, Gori J, Sasi S, et al. Prognostic nutritional index prior to rectal cancer resection predicts overall survival. Nutr Cancer. 2022;74(9):3228–3235. 2022/05/10. doi: 10.1080/01635581.2022.2072906.
   PubMed Web of Science ®Google Scholar
• Liu J, Dai Y, Zhou F, et al. The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy. Urol Oncol. 2016;34(11):484.e481–484.e488. doi: 10.1016/j.urolonc.2016.05.024.
   Web of Science ®Google Scholar
• Fang P, Yang Q, Zhou J, et al. The impact of geriatric nutritional risk index on esophageal squamous cell carcinoma patients with neoadjuvant therapy followed by esophagectomy. Front Nutr. 2022;9:983038. doi: 10.3389/fnut.2022.983038.
   PubMed Web of Science ®Google Scholar
• Jia-Min Z, Wei D, Ye L, et al. Correlation between C-reactive protein/albumin ratio and prognosis in patients with lung adenocarcinoma. J Int Med Res. 2022;50(6):3000605221105372. doi: 10.1177/03000605221105372.
   Web of Science ®Google Scholar
• Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutricion Hospitalaria. 2005;20:38–45.
   PubMedGoogle Scholar
• Zhu M, Chen L, Kong X, et al. Controlling nutritional status (CONUT) as a novel postoperative prognostic marker in breast cancer patients: a retrospective study. Biomed Res Int. 2022;2022:3254523–3254581. doi: 10.1155/2022/3254581.
   Web of Science ®Google Scholar
• Nakamura N, Kanemura N, Lee S, et al. Prognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma. Leuk Lymphoma. 2022;63(6):1323–1330. doi: 10.1080/10428194.2021.2020777.
   PubMed Web of Science ®Google Scholar
• Demir M, Demircan NC. The CONUT score is prognostic in esophageal cancer treated with chemoradiotherapy. Saudi J Gastroenterol. 2023;29(2):119–126. doi: 10.4103/sjg.sjg_384_22.
   PubMed Web of Science ®Google Scholar
• Dalmiglio C, Brilli L, Campanile M, et al. CONUT score: a new tool for predicting prognosis in patients with advanced thyroid cancer treated with TKI. Cancers (Basel). 2022;14(3):724. doi: 10.3390/cancers14030724.
   PubMed Web of Science ®Google Scholar
• Cui P, Pang Q, Wang Y, et al. Nutritional prognostic scores in patients with hilar cholangiocarcinoma treated by percutaneous transhepatic biliary stenting combined with 125I seed intracavitary irradiation: a retrospective observational study. Medicine (Baltimore). 2018;97(22):e11000. doi: 10.1097/md.0000000000011000.
   PubMed Web of Science ®Google Scholar
• Miyata T, Yamashita YI, Higashi T, et al. The prognostic impact of controlling nutritional status (CONUT) in intrahepatic cholangiocarcinoma following curative hepatectomy: a retrospective single institution study. World J Surg. 2018;42(4):1085–1091. doi: 10.1007/s00268-017-4214-1.
   PubMed Web of Science ®Google Scholar
• Utsumi M, Aoki H, Nishimura S, et al. Safety of surgical treatment for elderly patients with gallbladder carcinoma. Acta Med Okayama. 2019;73(3):241–246. doi: 10.18926/amo/56867.
   PubMed Web of Science ®Google Scholar
• Wang A, He Z, Cong P, et al. Controlling nutritional status (CONUT) score as a new indicator of prognosis in patients with hilar cholangiocarcinoma is superior to NLR and PNI: a Single-Center retrospective study. Front Oncol. 2020;10:593452. doi: 10.3389/fonc.2020.593452.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wu F, Rong W, et al. Prognostic value of the controlling nutritional status (CONUT) score in intrahepatic cholangiocarcinoma patients especially who had long-time alcohol consumption. J Clin Biochem Nutr. 2020;67(3):323–331. doi: 10.3164/jcbn.20-27.
   PubMed Web of Science ®Google Scholar
• Sun LJ, Su S, Xiong JP, et al. Controlling nutritional status score as a prognostic marker to predict overall survival in resected biliary tract cancers. Ann Transl Med. 2021;9(8):644–644. doi: 10.21037/atm-20-6770.
   PubMed Web of Science ®Google Scholar
• Terasaki F, Sugiura T, Okamura Y, et al. Use of preoperative controlling nutritional status (CONUT) score as a better prognostic marker for distal cholangiocarcinoma after pancreatoduodenectomy. Surg Today. 2021;51(3):358–365. doi: 10.1007/s00595-020-02098-0.
   PubMed Web of Science ®Google Scholar
• Yugawa K, Itoh S, Yoshizumi T, et al. Lymphocyte–C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma. Int J Clin Oncol. 2021;26(10):1901–1910. doi: 10.1007/s10147-021-01962-4.
   PubMed Web of Science ®Google Scholar
• Asakura R, Yanagimoto H, Ajiki T, et al. Prognostic impact of Inflammation-Based scores for extrahepatic cholangiocarcinoma. Dig Surg. 2022;39(2-3):65–74. doi: 10.1159/000521969.
   PubMed Web of Science ®Google Scholar
• Mito M, Sakata J, Hirose Y, et al. Preoperative controlling nutritional status score predicts systemic disease recurrence in patients with resectable biliary tract cancer. Eur J Surg Oncol. 2023;49(2):399–409. doi: 10.1016/j.ejso.2022.11.003.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi: 10.1007/s10654-010-9491-z.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558. doi: 10.1002/sim.1186.
   PubMed Web of Science ®Google Scholar
• Cochran W. The combination of estimates from different experiments. Biometrics. 1954;10(1):101–129. doi: 10.2307/3001666.
   Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2.
   PubMedGoogle Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute. 1959;22:719–748.
   PubMed Web of Science ®Google Scholar
• Sun LC, Chu KS, Cheng SC, et al. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer. 2009;9(1):288. doi: 10.1186/1471-2407-9-288.
   PubMedGoogle Scholar
• Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149–163. doi: 10.2217/fon.09.136.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi: 10.1038/nature07205.
   PubMed Web of Science ®Google Scholar
• Cortes VA, Busso D, Maiz A, et al. Physiological and pathological implications of cholesterol. Front Biosci (Landmark Ed). 2014;19(3):416–428. doi: 10.2741/4216.
   PubMedGoogle Scholar
• Shor R, Wainstein J, Oz D, et al. Low serum LDL cholesterol levels and the risk of fever, sepsis, and malignancy. Ann Clin Lab Sci. 2007;37(4):343–348.
   PubMed Web of Science ®Google Scholar
• Oneda E, Abu  Hilal M, Zaniboni A. Biliary  tract  cancer: current  medical  treatment  strategies. Cancers  (Basel). 2020;12(5):12. doi: 10.3390/cancers12051237.
   Web of Science ®Google Scholar
• Personeni N, Lleo A, Pressiani T, et al. Biliary tract cancers: molecular heterogeneity and new treatment options. Cancers (Basel). 2020;12(11):12. doi: 10.3390/cancers12113370.
   Web of Science ®Google Scholar
• Dou L, Shi M, Song J, et al. The prognostic significance of C-Reactive protein to albumin ratio in newly diagnosed acute myeloid leukaemia patients. Cancer Manag Res. 2022;14:303–316. doi: 10.2147/cmar.S343580.
   PubMed Web of Science ®Google Scholar
• Demirelli B, Babacan NA, Ercelep O, et al. Modified glasgow prognostic score, prognostic nutritional index and ECOG performance score predicts survival better than sarcopenia, cachexia and some inflammatory indices in metastatic gastric cancer. Nutr Cancer. 2021;73(2):230–238. doi: 10.1080/01635581.2020.1749290.
   PubMed Web of Science ®Google Scholar
• Kimura S, D’ Andrea D, Soria F, et al. Prognostic value of modified glasgow prognostic score in non-muscle-invasive bladder cancer. Urol Oncol. 2019;37(3):179.e19–179.e28. doi: 10.1016/j.urolonc.2018.11.005.
   PubMed Web of Science ®Google Scholar
• Momokita M, Abe A, Shibata K, et al. Prognostic nutritional index in patients with End-Stage oral cancer. Am J Hosp Palliat Care. 2023;40(4):396–400. doi: 10.1177/10499091221102581.
   PubMed Web of Science ®Google Scholar
• Nogueiro J, Santos-Sousa H, Pereira A, et al. The impact of the prognostic nutritional index (PNI) in gastric cancer. Langenbecks Arch Surg. 2022;407(7):2703–2714. doi: 10.1007/s00423-022-02627-0.
   PubMed Web of Science ®Google Scholar
• Quhal F, Pradere B, Laukhtina E, et al. Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer. World J Urol. 2021;39(9):3345–3352. doi: 10.1007/s00345-020-03586-1.
   PubMed Web of Science ®Google Scholar
• Taguchi S, Kawai T, Nakagawa T, et al. Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study. Sci Rep. 2021;11(1):15623. doi: 10.1038/s41598-021-95061-z.
   PubMed Web of Science ®Google Scholar
• Cesur IB, Özçelik Z. Systemic Immune-Inflammation index may predict mortality in neuroblastoma. Cureus. 2023;15(3):e35705. doi: 10.7759/cureus.35705.
   PubMed Web of Science ®Google Scholar
• Jan HC, Wu KY, Tai TY, et al. The systemic Immune-Inflammation index (SII) increases the prognostic significance of lymphovascular invasion in upper tract urothelial carcinoma after radical nephroureterectomy. Cancer Manag Res. 2022;14:3139–3149. doi: 10.2147/cmar.S378768.
   PubMed Web of Science ®Google Scholar
• Han W, Weng K, Zhang P, et al. Predictive value of systemic immune-inflammation index for pathological complete response in patients receiving neoadjuvant immunochemotherapy for locally advanced esophageal cancer. Front Surg. 2022;9:1091601. doi: 10.3389/fsurg.2022.1091601.
   PubMed Web of Science ®Google Scholar
• Feng L, Xu R, Lin L, et al. Effect of the systemic immune-inflammation index on postoperative complications and the long-term prognosis of patients with colorectal cancer: a retrospective cohort study. J Gastrointest Oncol. 2022;13(5):2333–2339. doi: 10.21037/jgo-22-716.
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Makinoya M, Sunaguchi T, et al. Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer. PLoS One. 2022;17(7):e0271073. doi: 10.1371/journal.pone.0271073.
   PubMedGoogle Scholar
• Si Y, Xu P, Xu A, et al. Geriatric nutritional risk index as a prognostic factor in patients with hepatocellular carcinoma following transarterial chemoembolization: a retrospective study. Medicine (Baltimore). 2022;101(51):e32322. doi: 10.1097/md.0000000000032322.
   PubMed Web of Science ®Google Scholar
• Riveros C, Chalfant V, Bazargani S, et al. The geriatric nutritional risk index predicts complications after nephrectomy for renal cancer. Int Braz J Urol. 2023;49(1):97–109. doi: 10.1590/s1677-5538.Ibju.2022.0380.
   PubMed Web of Science ®Google Scholar
• Huang YY, Liu X, Liang SH, et al. Prognostic value of preoperative C-reactive protein to albumin ratio in patients with thymic epithelial tumors: a retrospective study. BMC Cancer. 2022;22(1):1183. doi: 10.1186/s12885-022-10234-x.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen L, Sun F, et al. C-Reactive protein/albumin ratio on the first day after surgery predicts Short-Term complications of gastrectomy for gastric cancer. Nutr Cancer. 2022;74(10):3574–3581. doi: 10.1080/01635581.2022.2083190.
   PubMed Web of Science ®Google Scholar
• Xue W, Hu X, Zhang Y. The association of controlling nutritional status (CONUT) score with survival in patients with surgically treated renal cell carcinoma and upper tract urothelial carcinoma: a systematic review and Meta-Analysis. Nutr Cancer. 2022;74(6):1907–1916. doi: 10.1080/01635581.2021.1974894.
   PubMed Web of Science ®Google Scholar
• Zhang C, Li XK, Cong ZZ, et al. Controlling nutritional status is a prognostic factor for patients with lung cancer: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(4):3896–3905. doi: 10.21037/apm-20-2328.
   PubMed Web of Science ®Google Scholar
• Peng J, Hao Y, Rao B, et al. Prognostic impact of the pre-treatment controlling nutritional status score in patients with non-small cell lung cancer: a meta-analysis. Medicine (Baltimore). 2021;100(26):e26488. doi: 10.1097/md.0000000000026488.
   PubMed Web of Science ®Google Scholar
• Ma X, Zou W, Sun Y. Prognostic value of pretreatment controlling nutritional status score for patients with pancreatic cancer: a Meta-Analysis. Front Oncol. 2021;11:770894. doi: 10.3389/fonc.2021.770894.
   PubMed Web of Science ®Google Scholar
• Takagi K, Buettner S, Ijzermans JNM, et al. Systematic review on the controlling nutritional status (CONUT) score in patients undergoing esophagectomy for esophageal cancer. Anticancer Res. 2020;40(10):5343–5349. doi: 10.21873/anticanres.14541.
   PubMed Web of Science ®Google Scholar
• Takagi K, Buettner S, Ijzermans JNM. Prognostic significance of the controlling nutritional status (CONUT) score in patients with colorectal cancer: a systematic review and meta-analysis. Int J Surg. 2020;78:91–96. doi: 10.1016/j.ijsu.2020.04.046.
   PubMed Web of Science ®Google Scholar
• Peng L, Meng C, Li J, et al. The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis. Eur J Clin Nutr. 2022;76(6):801–810. doi: 10.1038/s41430-021-01014-0.
   PubMed Web of Science ®Google Scholar
• Lu C, Chen Q, Fei L, et al. Prognostic impact of the controlling nutritional status score in patients with hematologic malignancies: a systematic review and meta-analysis. Front Immunol. 2022;13:952802. doi: 10.3389/fimmu.2022.952802.
   PubMed Web of Science ®Google Scholar